Results 11 to 20 of about 1,126,665 (298)

HLA-G/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers

open access: yesFrontiers in Immunology, 2021
As a non-classic major histocompatibility complex (MHC) class I molecule, human leukocyte antigen G (HLA-G) is expressed in fetal-maternal interface and immunoprivileged site only in healthy condition, and in pathological conditions such as cancer, it ...
Peilong Li   +10 more
doaj   +1 more source

Urinary CE-MS peptide marker pattern for detection of solid tumors [PDF]

open access: yes, 2018
Urinary profiling datasets, previously acquired by capillary electrophoresis coupled to mass-spectrometry were investigated to identify a general urinary marker pattern for detection of solid tumors by targeting common systemic events associated with ...
Belczacka, Iwona   +8 more
core   +2 more sources

Exosomal and intracellular miR-320b promotes lymphatic metastasis in esophageal squamous cell carcinoma

open access: yesMolecular Therapy: Oncolytics, 2021
Cancer-cell-released exosomal microRNAs (miRNAs) are important mediators of cell-cell communication in the tumor microenvironment. In this study, we sequenced serum exosome miRNAs from esophageal squamous cell carcinoma (ESCC) patients and identified ...
Tong Liu   +10 more
doaj   +1 more source

The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses [PDF]

open access: yes, 2011
Background: Cancer antigen 125 (CA125) is the best known single tumor marker for ovarian cancer (OC). We investigated whether the additional information of the human epididymis protein 4 (HE4) improves diagnostic accuracy.
Burges, Alexander   +9 more
core   +1 more source

Neuroendocrine Tumor Markers

open access: yesFrontiers in Neuroendocrinology, 2001
Tumor markers used in the diagnosis and follow-up of patients with neuroendocrine tumors are in most instances not specific for a given tumor and circulate under normal conditions in the serum, making their use as an early diagnostic tool difficult (low sensitivity).
Lamberts, S.W.J.   +2 more
openaire   +2 more sources

Construction of Multicolor Upconversion Nanotheranostic Agent for in-situ Cooperative Photodynamic Therapy for Deep-Seated Malignant Tumors

open access: yesFrontiers in Chemistry, 2020
Upconversion nanoparticles (UCNPs)-based photodynamic nanotheranostic agents could address the main drawbacks of photosensitizer molecules (PSs) including instability in aqueous solution and rapid clearance.
Tongtong Hong   +7 more
doaj   +1 more source

Components of cell-matrix linkage as potential new markers for prostate cancer [PDF]

open access: yes, 2011
Prostate cancer is one of the most common tumor diseases worldwide. Often being non-aggressive, prostate tumors in these cases do not need immediate treatment.
Eble, Johannes Andreas, Navdaev, Alexey
core   +2 more sources

Detection of Tumor Cell-Specific mRNA in the Peripheral Blood of Patients with Breast Cancer-Evaluation of Several Markers with Real-Time Reverse Transcription-PCR [PDF]

open access: yes, 2013
It is widely known that cells from epithelial tumors, e. g., breast cancer, detach from their primary tissue and enter blood circulation. We show that the presence of circulating tumor cells (CTCs) in samples of patients with primary and metastatic ...
Alexandra Kölbl   +55 more
core   +3 more sources

Tumor Marker Workshops

open access: yesTumor Biology, 2003
Since 1996, the nine ISOBM Workshops have so far characterized more than 300 monoclonal antibodies to a variety of tumor markers that include CA125, AFP, PSA, MUC1, Cytokeratins, Sialyl Le(a), hCG, CEA, ALP, and more recently SCC, and S100. Besides the basic characterization of antibodies and their epitope configurations, several workshops have also ...
P D, Rye, K, Nustad, T, Stigbrand
openaire   +2 more sources

Simultaneous Determination of Urinary CEA, Ferritin and TPA in Egyptian Bladder Cancer Patients

open access: yesThe International Journal of Biological Markers, 1992
Urinary carcinoembryonic antigen (CEA), ferritin (Fer) and tissue polypeptide antigen (TPA) were determined in 328 cases (106 with blader cancer, 152 with non-malignant urinary tract disease and 70 healthy controls).
A.-B. Halim   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy